ComfortDelGro Corporation Limited (SGX:C52)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions SGD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,292	3,206	3,032	2,664	3,034	3,618
Market Cap Growth	5.73%	5.73%	13.80%	-12.18%	-16.16%	-29.81%
Enterprise Value	4,181	3,604	3,109	2,685	3,208	4,238
Last Close Price	1.52	1.44	1.29	1.07	1.17	1.37
PE Ratio	15.65	15.23	16.80	15.39	24.67	59.51
Forward PE	13.91	13.88	15.49	13.21	15.54	23.72
PS Ratio	0.74	0.72	0.78	0.71	0.87	1.12
PB Ratio	1.09	1.06	1.01	0.89	0.98	1.18
P/TBV Ratio	2.89	2.81	1.71	1.52	1.68	2.04
P/FCF Ratio	32.15	31.31	37.16	8.88	7.01	10.28
P/OCF Ratio	6.01	5.86	6.75	4.42	4.62	6.65
PEG Ratio	1.67	1.18	0.59	0.59	0.50	-
EV/Sales Ratio	0.93	0.81	0.80	0.71	0.92	1.31
EV/EBITDA Ratio	6.12	5.66	5.28	4.88	6.48	9.49
EV/EBIT Ratio	13.08	11.34	11.70	11.49	19.79	69.70
EV/FCF Ratio	40.83	35.20	38.10	8.95	7.42	12.04
Debt / Equity Ratio	0.45	0.45	0.18	0.17	0.20	0.24
Debt / EBITDA Ratio	1.99	1.99	0.84	0.85	1.15	1.50
Debt / FCF Ratio	13.23	13.23	6.47	1.68	1.43	2.11
Asset Turnover	0.86	0.86	0.83	0.79	0.71	0.63
Inventory Turnover	22.91	22.91	23.08	24.97	21.93	17.73
Quick Ratio	0.90	0.90	1.27	1.46	1.50	1.28
Current Ratio	1.06	1.06	1.48	1.58	1.64	1.41
Return on Equity (ROE)	8.47%	8.47%	7.48%	7.15%	4.95%	3.02%
Return on Assets (ROA)	3.81%	3.81%	3.54%	3.04%	2.05%	0.73%
Return on Capital (ROIC)	5.01%	5.01%	4.71%	4.04%	2.69%	0.99%
Return on Capital Employed (ROCE)	8.10%	8.10%	7.40%	6.40%	4.10%	1.50%
Earnings Yield	6.39%	6.57%	5.95%	6.50%	4.05%	1.68%
FCF Yield	3.11%	3.19%	2.69%	11.26%	14.26%	9.73%
Dividend Yield	5.08%	5.40%	5.15%	4.30%	3.59%	1.05%
Payout Ratio	74.92%	74.92%	55.90%	61.99%	62.20%	188.49%
Buyback Yield / Dilution	-0.02%	-0.02%	0.01%	0.03%	-0.03%	0.02%
Total Shareholder Return	4.87%	5.38%	5.16%	4.32%	3.56%	1.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.